Dexcom Inc

General

Total Cases69
Active Cases20
Patents903
TypeOperating Company
Elite Ratings
--

Ratings

Experience
Grade
Trend
DCT
L2
E
PTAB
L5
C
CAFC
L2
D

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
11/21/24
ORDER: In accordance with the Court's November 13, 2024 Order (D.I. [723] ), the Clerk's Office is hereby directed to unseal the Memorandum Opinion of November 13, 2024 (D.I. [721] ). Signed by Judge Kent A. Jordan on 11/21/2024. (mpb) (Entered: 11/21/2024)
11/21/24
SCHEDULING ORDER: Fact Discovery completed by 2/19/2026. Expert Discovery due by 7/31/2026. Dispositive Motions due by 8/27/2026. A Markman Hearing is set for 11/13/2025 at 01:00 PM in Courtroom 6B before Judge Gregory B. Williams. A Final Pretrial Conference for Abbott's Claims is set for 2/9/2027 at 03:00 PM in Courtroom 6B before Judge Gregory B. Williams. A Five-Day Jury Trial for Abbott's Claims is set for 2/15/2027 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams. A Final Pretrial Conference in DexCom's Claims is set for 3/2/2027 at 03:00 PM in Courtroom 6B before Judge Gregory B. Williams. A Five-Day Jury Trial in DexCom's Claims is set for 3/8/2027 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams. Signed by Judge Gregory B. Williams on 11/21/2024. (lnb) (Entered: 11/21/2024)
11/21/24
CORRECTING ENTRY: Updated Scheduling Order at D.I. 822 with Amended Table of Deadlines per the request of the Court. (lnb) (Entered: 11/21/2024)
11/21/24
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Expert Discovery due by 4/17/2026. Dispositive Motions due by 6/26/2026. Claim Construction Opening Brief due by 4/1/2025. Claim Construction Answering Brief due by 4/29/2025. Joint Claim Construction Brief due by 5/6/2025. A Markman Hearing is set for 9/18/2025 at 01:00 PM in Courtroom 6B before Judge Gregory B. Williams. A Final Pretrial Conference is set for 1/5/2027 at 03:00 PM in Courtroom 6B before Judge Gregory B. Williams. A 5-Day Jury Trial is set for 1/11/2027 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams. Signed by Judge Gregory B. Williams on 11/20/24. (jaa) Modified on 11/21/2024 (jaa). (Entered: 11/21/2024)
11/20/24
ORAL ORDER: IT IS HEREBY ORDERED that, by no later than 3 pm on November 22, 2024, counsel for Defendants shall email to chambers at gbw_civil@ded.uscourts.gov the Table of Deadlines, revised with the deadlines provided in the Scheduling Order entered today so the Court can add it as the last page of the Scheduling Order entered. ORDERED by Judge Gregory B. Williams on 11/20/24. (jaa) (Entered: 11/20/2024)
11/20/24
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Expert Discovery due by 4/17/2026. Dispositive Motions due by 6/26/2026. Claim Construction Opening Brief due by 4/1/2025. Claim Construction Answering Brief due by 4/29/2025. Joint Claim Construction Brief due by 5/6/2025. A Markman Hearing is set for 9/18/2025 at 01:00 PM in Courtroom 6B before Judge Gregory B. Williams. A Final Pretrial Conference is set for 1/5/2027 at 03:00 PM in Courtroom 6B before Judge Gregory B. Williams. A 5-Day Jury Trial is set for 1/11/2027 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams. Signed by Judge Gregory B. Williams on 11/20/24. (jaa) (Entered: 11/20/2024)
11/20/24
NOTICE OF SERVICE of Abbott's Objections and Responses to Dexcom's Fourth Set of Requests for Production (Nos. 347-351) - filed by Abbott Diabetes Care Inc., Abbott Diabetes Care Limited, Abbott Diabetes Care Sales Corp..(Raucci, Anthony) (Entered: 11/20/2024)
11/13/24
ORDER: Counsel shall provide the Court with proposed redactions to that document on or before the close of business on November 21, 2024. After that time the Court will unseal the Memorandum Opinion, setting forth the rulings, with any redactions deemed appropriate by the Court. Signed by Judge Kent A. Jordan on 11/13/2024. (mpb) (Entered: 11/13/2024)
11/13/24
ORDER: Dexcom Inc.'s Renewed Motion for Judgment as a Matter of Law and Motion for New Trial (D.I. [679] ) is GRANTED-IN-PART insofar as Dexcom argues that it did not willfully infringe the patents in suit. Dexcom's Renewed Motion for Judgment as a Matter of Law and Motion for New Trial (D.I. [679] ) is DENIED-IN-PART insofar as it argues that no reasonable jury could find it infringed claim 3 of U.S. Patent No. 11,000,216; that it is entitled to a new trial on infringement of claim 28 of U.S. Patent No. 10,959,649; and that Abbott Diabetes Care Inc. and Abbott Diabetes Care Ltd. ( collectively, "Abbott") are entitled to only a nominal reasonable royalty and not entitled to lost profits. Abbott's Renewed Motion for Judgment as a Matter of Law (D.I. [680] ) is GRANTED-IN-PART insofar as it argues that Dexcom infringed claim 3 of U.S. Patent No. 11,000,216; that it is entitled to a non-zero reasonable royalty; and that it is entitled to a new trial on damages. Abbott's Renewed Motion for Judgment as a Matter of Law (D.I. [680] ) is DENIED-IN-PART insofar as it argues that Dexcom infringed claim 3 of U.S. Patent No. 10,945,647; that it is entitled to lost profits as a matter of law; and that it is entitled to a new trial on willfulness and on infringement of claim 3 of U.S. Patent No. 10,945,647. Signed by Judge Kent A. Jordan on 11/13/2024. (mpb) (Entered: 11/13/2024)
11/13/24
[SEALED] MEMORANDUM OPINION Signed by Judge Kent A. Jordan on 11/13/2024.This order has been emailed to local counsel. (mpb) (Main Document 721 replaced on 11/13/2024) (mpb). (Entered: 11/13/2024)